You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • P87 Mesenchymal splice isoform fibroblast growth factor receptor (FGFR2c) is an independent prognostic biomarker and further refines risk stratification within endometrial cancer molecular subtypes

Article metrics

Article menu
Download PDFPDF
Poster exhibition Day 1
P87 Mesenchymal splice isoform fibroblast growth factor receptor (FGFR2c) is an independent prognostic biomarker and further refines risk stratification within endometrial cancer molecular subtypes

 

Online download statistics by month:

Online download statistics by month: November 2019 to September 2024

AbstractFullPdf
Nov 20192101
Dec 20191000
Jan 2020600
Feb 20202701
Mar 20201501
Apr 20202000
May 20202100
Jun 20203702
Jul 20202100
Aug 20202500
Sep 20203101
Oct 20207000
Nov 20205101
Dec 20202400
Jan 20211401
Feb 2021601
Mar 2021900
Apr 2021600
Oct 2021600
Nov 2021400
Dec 20211600
Jan 20221000
Feb 20221200
Mar 20221200
Apr 20221600
May 20221600
Jun 20221400
Jul 20221800
Aug 20221201
Sep 2022800
Oct 2022400
Nov 2022400
Dec 20222000
Jan 2023400
Feb 20231100
Mar 20232800
Apr 2023600
May 2023600
Jun 2023400
Jul 2023800
Aug 2023600
Sep 2023400
Oct 20231800
Nov 2023600
Dec 20231000
Jan 2024400
Feb 2024400
Mar 20241801
Apr 20241200
May 2024800
Jun 20241600
Aug 20242201
Sep 2024800
Total789012